Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CTSV | O60911 | 1/20 | 0.30 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1765069 | 1.00 | FAAH (0.34) | FAAHGAAALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL29814837 | 1.00 | FAAH (0.34) | FAAHGAAALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL1765540 | 1.00 | FAAH (0.34) | FAAHGAAALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL1120023 | 0.84 | ALDH1A1 (0.34) | FAAHGAAALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL1765621 | 0.83 | GAA (0.41) | GAAALDH1A1SMN1; SMN2LMNAHPGD | |
| SCHEMBL1765072 | 0.83 | GAA (0.41) | GAAALDH1A1SMN1; SMN2LMNAHPGD | |
| SCHEMBL1765070 | 0.83 | GAA (0.41) | GAAALDH1A1SMN1; SMN2LMNAHPGD | |
| SCHEMBL440115 | 0.82 | HRH3 (0.35) | GAAALDH1A1KMT2AMEN1LMNA | |
| SCHEMBL15446675 | 0.82 | ALDH1A1 (0.43) | GAAALDH1A1KMT2APPARGHPGD | |
| SCHEMBL1119900 | 0.81 | ALDH1A1 (0.36) | FAAHGAAALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110124501-A1 | Active compound combinations | BAYER CROPSCIENCE AG (DE) | 2011-05-26 | — | — | US | claimed |
| US-20110124501-A1 | Active compound combinations | BAYER CROPSCIENCE AG (DE) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124501-A1 | Active compound combinations | CYP51A1, CA4, BROX | FAAH 2218/4885GAA 90/4885ALDH1A1 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.